MD Mednax Inc

Price (delayed)

$29.69

Market cap

$2.56B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$9.09

Enterprise value

$3.35B

Highlights
The debt has plunged by 52% YoY and by 42% from the previous quarter
The company's EPS rose by 41% YoY and by 4.8% QoQ
The equity is down by 48% YoY but it is up by 2.6% QoQ
Mednax's gross profit has decreased by 12% YoY but it has increased by 7% from the previous quarter
The quick ratio has declined by 43% since the previous quarter and by 25% year-on-year
The gross margin has declined by 7% year-on-year

Key stats

What are the main financial stats of MD
Market
Shares outstanding
86.28M
Market cap
$2.56B
Enterprise value
$3.35B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.32
Price to sales (P/S)
1.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.83
Earnings
Revenue
$1.83B
EBIT
-$648.71M
EBITDA
-$630.91M
Free cash flow
$244.74M
Per share
EPS
-$9.09
Free cash flow per share
$2.9
Book value per share
$8.95
Revenue per share
$21.69
TBVPS
$11.59
Balance sheet
Total assets
$2.48B
Total liabilities
$1.72B
Debt
$1.06B
Equity
$766.76M
Working capital
$338.44M
Liquidity
Debt to equity
1.38
Current ratio
2.04
Quick ratio
1.88
Net debt/EBITDA
-1.25
Margins
EBITDA margin
-34.4%
Gross margin
26.2%
Net margin
-41.5%
Operating margin
6.2%
Efficiency
Return on assets
-24%
Return on equity
-96.7%
Return on invested capital
-29.6%
Return on capital employed
-30.1%
Return on sales
-35.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MD stock price

How has the Mednax stock price performed over time
Intraday
1.96%
1 week
1.54%
1 month
-1.17%
1 year
48.6%
YTD
20.99%
QTD
-1.53%

Financial performance

How have Mednax's revenue and profit performed over time
Revenue
$1.83B
Gross profit
$479.96M
Operating income
$113.78M
Net income
-$760.13M
Gross margin
26.2%
Net margin
-41.5%
The net income rose by 40% year-on-year and by 4.6% since the previous quarter
The net margin has increased by 38% YoY and by 10% from the previous quarter
MD's operating income is down by 28% year-on-year but it is up by 16% since the previous quarter
The operating margin has declined by 25% year-on-year but it has increased by 9% since the previous quarter

Growth

What is Mednax's growth rate over time

Valuation

What is Mednax stock price valuation
P/E
N/A
P/B
3.32
P/S
1.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.83
The company's EPS rose by 41% YoY and by 4.8% QoQ
The P/B is 95% above the 5-year quarterly average of 1.7 and 44% above the last 4 quarters average of 2.3
The equity is down by 48% YoY but it is up by 2.6% QoQ
The stock's price to sales (P/S) is 37% more than its last 4 quarters average of 1.0 but 2.1% less than its 5-year quarterly average of 1.4
The revenue has increased by 6% from the previous quarter but it has decreased by 4.3% YoY

Efficiency

How efficient is Mednax business performance
The company's return on sales rose by 40% YoY and by 8% QoQ
MD's return on equity is down by 37% year-on-year and by 17% since the previous quarter
The ROIC is up by 18% YoY but it is down by 13% from the previous quarter
The ROA has grown by 13% YoY but it has contracted by 9% from the previous quarter

Dividends

What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MD.

Financial health

How did Mednax financials performed over time
The total assets is 45% greater than the total liabilities
The quick ratio has declined by 43% since the previous quarter and by 25% year-on-year
The total assets has declined by 43% year-on-year and by 26% since the previous quarter
The debt is 38% more than the equity
The debt has plunged by 52% YoY and by 42% from the previous quarter
The equity is down by 48% YoY but it is up by 2.6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.